We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The requirements for 3D printed products will depend on whether they are classed as medical devices, personal protective equipment (PPE) or both.
Guidance for industry on flexible approaches we are taking on good distribution practices.
Actions that trial sponsors should consider to build resilience into clinical trial design
What you need to do to supply investigational medicinal products (IMPs) from Great Britain to Northern Ireland.
Access Consortium Statement on Good Manufacturing Practice (GMP) Inspections Reliance and Recognition
Information on the measures in the Health Service Medical Supplies (Costs) Bill.
Provide innovators and developers of innovative products access to MHRA scientific expertise, regulatory guidance and an enhanced advice and signposting service.
A 5-year voluntary scheme on the control of prices agreed between government and the Association of the British Pharmaceutical Industry (ABPI).
Confirmation of the regulation 251 of the Human Medicines Regulation following the Brexit transition.
What 'single-use' means and what symbol is used by manufacturers to show this.
The MHRA has published advice for patients and healthcare professionals
The UK Good Laboratory Practice Monitoring Authority (UK GLPMA) recognises that there are potential challenges COVID-19 will present to members of the GLP monitoring programme.
This guidance sets out how the MHRA is handling centralised applications that were still pending on 1 January 2021.
How we engage and involve patients and the public in our regulatory decision-making.
The pre-clinical evaluation team at VDEC provides a safe and controlled environment to test new vaccines and therapeutics before they progress to clinical trials
Guidance for industry on preparing responses to good laboratory practice (GLP) and good clinical practice (GCP) inspection reports.
Labelling requirements for e-liquids.
Resources for pharmacies to achieve Healthy Living Pharmacy (HLP) Level 1 status.
Information to raise awareness with commissioners and providers of the community pharmacy offer for sexual health, reproductive health and HIV services.
For manufacturers reporting adverse incidents with joint replacement implants under the vigilance system.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).